To view the Editor's Choice articles listed below, access as a:

CNSF Member - through the CNSF Member's Centre
(CNSF Username & Password required).

Journal Subscribers (non-CNSF members) - directly the Journal
(Journal User Name & Password Required).

Not a CNSF Member or Journal Subscriber - Interested in Purchasing a Particular Article? You need to register first. Why? Register today!

2011

September 2011 Complications in MS Patients after CCSVI Procedures Abroad (Calgary, AB) Jodie M. Burton, Katayoun Alikhani, Mayank Goyal, Fiona Costello, Chris White, David Patry, Robert Bell, Michael D. Hill July 2011 Tauopathies: One Disease or Many? Manon Bouchard, Oksana Suchowersky May 2011 Stroke in Young Women Meredith Salisbury, Gerald Pfeffer, Samuel Yip March 2011 Carotid Endarterectomy Versus Stenting: AMeta-Analysis of Randomized Trials Daniel Yavin, Derek J. Roberts, Michael Tso, Garnette R. Sutherland, Misha Eliasziw, John H. Wong January 2011 The ASPIRE Approach for TIA Risk Stratification S.B. Coutts, P.N. Sylaja, Y.B. Choi, A. Al-Khathami, C. SivaKumar, T.J. Jeerakathil, P.S. Sarma, M.D. Hill for the Calgary Stroke Program

To view the Editor's Choice articles listed below, access as a:

CNSF Member - through the CNSF Member's Centre
(CNSF Username & Password required).

Journal Subscribers (non-CNSF members) - directly the Journal
(Journal User Name & Password Required).

Not a CNSF Member or Journal Subscriber - Interested in Purchasing a Particular Article? You need to register first. Why? Register today!

2011	September 2011 Complications in MS Patients after CCSVI Procedures Abroad (Calgary, AB) Jodie M. Burton, Katayoun Alikhani, Mayank Goyal, Fiona Costello, Chris White, David Patry, Robert Bell, Michael D. Hill July 2011 Tauopathies: One Disease or Many? Manon Bouchard, Oksana Suchowersky May 2011 Stroke in Young Women Meredith Salisbury, Gerald Pfeffer, Samuel Yip March 2011 Carotid Endarterectomy Versus Stenting: AMeta-Analysis of Randomized Trials Daniel Yavin, Derek J. Roberts, Michael Tso, Garnette R. Sutherland, Misha Eliasziw, John H. Wong January 2011 The ASPIRE Approach for TIA Risk Stratification S.B. Coutts, P.N. Sylaja, Y.B. Choi, A. Al-Khathami, C. SivaKumar, T.J. Jeerakathil, P.S. Sarma, M.D. Hill for the Calgary Stroke Program
2010	November 2010 Observations on the Ethical and Social Aspects of Disorders of Consciousness Eric Racine, Catherine Rodrigue, James L. Bernat, Richard Riopelle, Sam D. Shemie September 2010 Blunt Cerebrovascular Injuries: Diagnosis and Management Outcomes Corie W. Wei, Walter Montanera, Daniel Selchen, Jackie Lian, Christopher Stevens, Lyne Noël de Tilly July 2010 Electroencephalographic Features of Temporal Lobe Epilepsy Mohammed M. Jan, Mark Sadler, Susan R. Rahey May 2010 Early Onset Epilepsy and Inherited Metabolic Disorders: Diagnosis and Management Asuri N. Prasad, G.F. Hoffmann March 2010 Current Evaluation and Management of Excessive Daytime Sleepiness M.I. Boulos, B.J. Murray Jan. 2010 Pseudoprogression Following Chemoradiotherapy for Glioblastoma Multiforme Paul Sanghera, James Perry, Arjun Sahgal, Sean Symons, Richard Aviv, Meredith Morrison, Kelvin Lam, Phillip Davey, May N. Tsao
2009	November 2009 Febrile Seizures: Current Views and Investigations Aylin Y. Reid, Michael A. Galic, G. Campbell Teskey, Quentin J. Pittman Sept. 2009 α-B-Crystallin as a Tissue Marker of Epileptic Foci in Paediatric Resections Harvey B. Sarnat, Laura Flores-Sarnat July 2009 Defining the CT Angiography ‘Spot Sign’ in Primary Intracerebral Hemorrhage Andrew L. Thompson, Jayme C. Kosior, David J. Gladstone, Julia J. Hopyan, Sean P. Symons, Francisco Romero, Imanuel Dzialowski, Jayanta Roy, Andrew M. Demchuk, Richard I. Aviv, for the PREDICT/Sunnybrook ICH CTA Study Group May 2009 NeuroAIDS: An Evolving Epidemic Christopher Power, Lysa Boissé, Sean Rourke, M. John Gill March 2009 Movements in Brain Death: A Systematic Review Gustavo Saposnik, Vincenzo S. Basile, G. Bryan Young Jan 2009 Systemic Lupus Erythematosus and Right Leg Weakness J.L. Steckley, M.C. Tartaglia, H. Reddy, S. Huang, R. Hammond, C. Hyson
2008	November 2008 Hemicraniectomy for Massive Middle Cerebral Artery Infarction: A Review Dulka Manawadu, Ahmed Quateen, J. Max Findlay September 2008 Neurocritical Care in Canada: Evolving Streams in a New Discipline Eyad Al Thenayan, Charles Bolton, Draga Jichici, Martin Savard, Jeanne Teitelbaum, Bryan Young, David Zygun

for March 2012

The following are accepted papers for the upcoming November publication, but not yet printed.

BRIEF COMMUNICATIONS Title-Spinal Epidural Arteriovenous Fistula with Double Perimedullary Reflux Outcomes of Nerve Transfer Versus Nerve Graft in Ulnar Nerve Laceration A Novel Exon 3 Mutation (P66S) in the SOD1 Gene in Familial ALS Proven or Unproven? Panel Report on Ethics in the Translation of Neuroscience Autoantibody Associated Disorders of the CNS in Children: The List Keeps Growing COMMENTARY HISTORICAL REVIEW EDITORIAL LETTERS TO THE EDITOR Atypical Multiple Lipomatosis as Sole Manifestation of a Mitochondrial Disorder Steroid-Dependant Idiopathic Caseating Intracranial Granuloma Paraneoplastic Anti-HU Syndrome Associated with Uterine Tumor Spontaneous Occlusion of the Temporal AVM Associated with Tinnitus NEUROIMAGING HIGHLIGHT Cerebral Abscess Crossing Midline OBITUARY ORIGINAL ARTICLE Eye Exercises for Treatment of Idiopathic Cranial nerve VII Paresis: Pilot Study Iron Deficiency Anemia Prevalence at First Stroke or Transient Ischemic Attack Treatment Comfort of Adult Neurologists in Childhood Onset Conditions Surgery for Unruptured Intracranial Aneurysms in the ISAT and ISUIA Era Multiple Sclerosis Fatique is Associated with Reduced Psychomotor Vigilance Pathologic Evaluation of the Supraoptic and Paraventricular Nuclei in Dementia Serum-Positive and -Negative AQP4 Antibody NMO in Chinese Patients Health Status, Stress and Life Satisfaction in a Community Population with MS Patients Referred for TIA May Still Have Persisting Neurological Deficits A Novel PLP1 Mutation Further Expands the Clinical Heterogeneity at the Locus Effects of Creatine and Exercise on Skeletal Muscle of FRG1-Transgenic Mice Increased Intestinal Permeability and Parkinson Disease Patients: Chicken or Egg? REVIEW ARTICLE Status Epilepticus" A Review, With Emphasis on Refractory Cases Autoimmune Encephalopathies and Epilepsies in Children and Teenagers Stem Cell in Brain Tumour Development and Therapy - Two Sides of the Same Coin

CNSF Members -
Access the Journal online through the CNSF Member's Centre (CNSF Username & Password required).

Journal Subscribers (non-CNSF members) -
Access directly the Journal (Journal User Name & Password Required).

Not a CNSF Member or Journal Subscriber -
Interested in Purchasing a Particular Article? You need to register first. Why? Register today!

Before submitting a manuscript to the CJNS, please ensure that you have read and adhered to the following:

General Manuscript Specifications (Applicable to ALL Manuscript Categories)

• Download PDF

Specific Manuscript Specification

Please click on Manuscript Category to view PDF and download specifications.

In the Spotlight: Featuring Resident and New Authors (January 2012). Review Articles Original Articles

Review Article Invited Unsolicited Original Article

Autobiography Basic Neuroscience Brief Communications (formerly Case Reports) Clinical Neuropathological Conference (CNPCs) Commentary Critically Appriased topics (CATs) Editorial Historical Article Letters to the Editor Medical Hypothesis Neuroimaging Highlights Reflections Obituary Reflections

Supplement Publication Services (In Development)

Exchange Articles (In Development)

Submit Manuscript Electronically

http://cjns.allentrack.net/cgi-bin/main.plex

To assist new and current authors during the writing process the CJNS has created the following tools:

• CJNS Proofreading Guidelines
• Medline Journal Abbreviations
• Uniform Requirements for Citations
• Proofreading Symbol

The goal of the CJNS is to work collaboratively with authors to publish Manuscripts in a timely manner. Manuscripts are to be published within 6 months of receiving final revisions from the author.

Once a Manuscript is received by CJNS, the review process applied is:

Editorial Coordinator

Initial Quality Control

• General Manuscript Specifications Apply.
• Specific Manuscript Specifications Apply.
• Journal page maximum met.

Editor-in-Chief Reviews

Specifically Looking For:

• Professionally Presented Manuscript
  (proper spelling, grammar, clarity, readability, etc.)
• Relevance to CJNS Subscribers
• Overall First Impressions (rating) of Manuscript. May include initial decision to reject/select associate editor.
• If conditionally approved for review Manuscript goes to Associate Editor

Associate Editor Reviews

Specifically Looking for:

• Associate Editor Review Checklist Applies. May include initial decision to reject/select associate editor.
• If approved for formal review Manuscript goes to up to 3 Reviewers for peer review, dependent on Manuscript Category as per Author Specific Manuscript Specifications.

Peer Reviewer Selected

Specifically Looking for:

• Formal Peer Review Checklist Applies.

http://cjns.allentrack.net/cgi-bin/main.plex

CJNS Issues and Supplements

Once a CJNS Issue and/or Supplement is posted within the CJNS online Journal, notification is provided to PubMED through Metapress. This notification may take upto one week from a Journal Issue or Supplement being uploaded to the CJSN online Journal. Upon receipt of notification, PubMED may take upto 72 hours to post Journal Issues online.

As PubMED is an organization outside of the CJNS, we do not have influence on how and when they post articles within their database. Should you have concerns, please contact the contact NLM Customer Service directly at custserv@nlm.nih.gov.

CJNS Supplements

Upon notification of supplements being posted on the CJNS online Journal, the following process occurs at PubMED:

• All supplements are tentatively hidden after they have been loaded and it is discerned whether the supplement conflicts with the International Committee of Medical Journal Editors policies. Visit http://www.icmje.org/#conflicts for more information.
• After supplements have been reviewed and confirmed with proper conflict of interest disclosures, the citations will be "unhidden" and be available again in PubMed.
• Supplements published in 2008 and later, it will be required that author disclosure statements appear within the paginated text of the article.
• Refer to the NLM Fact Sheet regarding Conflict of Interest Disclosure and Journal Supplements in MEDLINE for detailed information: http://www.nlm.nih.gov/pubs/factsheets/supplements.html
• As this is an involved review process PubMED is unable to provide an exact timeline, though this process can take several months.

The CJNS recognizes the importance of research conducted by Canadian Researchers utilizing CIHR Grants and the importance of Knowledge Translation as part of the CIHR Grant Submissions.

The CJNS recognizes the importance of research conducted by Canadian Researchers utilizing CIHR Grants and the importance of Knowledge Translation as part of the CIHR Grant Submissions.

The CJNS will allow CIHR researchers/ authors to upload an article within the open access PubMed Central Canada (PMC Canada) repository, provided a one time Open Access Publishing Fee is paid to the CJNS.

Please note:

• Articles published to the PMC Canada repository are also shared with the U.S. and UK PMC repositories.
• CIHR has provision for an Open Access Publishing Fee within the budget section of the application process.
• It is the author/ researchers responsibility to ensure they have permission to post closed-access articles within an open-access repository.

The CJNS Open Access Publishing Fee covers:

• Immediate Open Access of one article from time of publication within CJNS
  (instead of 5 years as of the 2010 policy)
• Permission to post the one article within the PMC repository.
• CJNS retains the ownership of all article contents.

CJNS Open Access Publishing Fee:

CNSF Members
$1,000.00/ article for first open access repository upload

Non-CNSF Members
$2,000.00/ article for first open access repository upload

The CJNS invites authors to submit manuscripts in the following categories*:

• Review Articles
• Original Articles
• Neuroimaging Highlights
• In the Spotlight: Highlighting Residents and First Time Authors
  (Review Articles and Original Articles

*View a complete list of CJNS Manuscript Categories within the 'Submission Process' section.

Currently Seeking

The CJNS is seeking high quality manuscripts on:

• Neurosurgery and Child Neurology topics
• Concussion and cumulative brain injury
• Prognositic detemination after traumatic brain injury
• Tauopathies
• Promising new anti-epileptic drugs
• Ethics in neurology and neurosurgery
• Attention Deficit Hyperactivity Disorder (ADHD)
• Complex Regional Pain Syndrome
• Congenital Anomalies of the Central Nervous System and Spine
• Creutzeldt-Jakob Disease
• Degenerative Disorders of the Spine
• Global Development Delay
• Huntington’s Disease
• Hydrocephalus
• Myasthenia Gravis
• Peripheral Neuropathy
• Spinocerebellar Ataxias
• Trigeminal Neuralagia

The Canadian Journal of Neurological Sciences (CJNS) is:

• the official publication of the four member societies of the Canadian Neurological Sciences Federation:
  • Canadian Neurological Society (CNS)
  • Canadian Association of Child Neurology (CACN)
  • Canadian Neurosurgical Society (CNSS)
  • Canadian Society of Clinical Neurophysiologists (CSCN).
• a high quality Canadian Medical Journal inviting authors to share clinical and basic neuroscience research occurring in Canada and abroad.
• widely circulated internationally to institutions and individual subscribers in Canada, the United States of America, South America, Asia and Africa .
• recognized as a peer-reviewed medical journal.
• published in January, March, May, July, September, and November.

The Editor-in-Chief and the Board encourage authors to send the final version of their work to the Journal for possible publication. All submissions received by the CJNS undergo detailed and careful peer-reviewed scrutiny.

The CJNS’s combined approach to neurology, neurosurgery, clinical neurophysiology and pediatric neurology offers authors a significant advantage over other journals that may be available to them for publication.

The goal of the CJNS is to work collaboratively with authors to publish Manuscripts in a timely manner. Manuscripts are to be published within 6 months of receiving final revisions from the author.

The Journal is published in January, March, May, July, September, and November.